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Case Presentation

A 55 year-old male with past medical history significant for mental
retardation, a stage IV sacral decubitous ulcer, iron deficiency
anemia and gastrointestinal bleeding presented from a long term
care facility for acute onset of respiratory distress and change in
mental status. On presentation the patient was found to have a
GCS of three, and he was emergently intubated in the emergency
department for airway protection. Following intubation his vital
signs were stable.
Upon review of his recent lab work, it was noted that patient had
hemoglobin (Hgb) of 6.4g/dL the day prior to admission with
a known baseline of 8g/dL. A blood transfusion was ordered.
However, the transfusion was delayed secondary to difficulties in
cross matching the patient’s blood. His admission labs returned
with a Hgb of 2.6g/dL, a stool guiac test was negative, and an
elevated LDH as well as positive direct Coombs C3 complement
and IgG were noted. The patient was transfused two units of Oblood while the blood bank worked to determine which antibodies
the patient had and find a suitable match. Eventually, the patient
was diagnosed with cold agglutinin autoimmune hemolytic anemia
based on an increase in his cold agglutin IgM antibody titer. At that
time, the options were to either delay further transfusion as it would
potentially worsen the hemolysis or to transfuse warmed blood.
Shortly after admission the patient became febrile, hypotensive
and tachycardic. Despite treatment with antibiotics and fluids,
the patient lost his pulse and required cardiopulmonary
resuscitation. Lab work during the code showed a Hgb of 2.7 g/
dL, and the patient was given additional units of warmed blood.
Unfortunately, the patient did not respond and expired within 24
hours of admission.

Discussion

Autoimmune hemolytic anemia (AIHA) is a disease in which
antibodies bind to red blood cell surface antigens and initiate
blood cell destruction. AIHA can be classified into warm and cold
reactive antibody disease. With cold agglutinin AIHA, it is thought
that the antibody binds to blood cells in the periphery (since blood
cools as it passes through the smaller peripheral vessels), activating
a complement cascade to the stage of C3b. C3b continues to adhere
to the red blood cells (RBCs) while they are in circulation. The C3bcoated RBCs encounter receptor specific macrophages, which then
engulf the RBCs and are cleared in the liver.

Cold agglutinin AIHA can range in severity from mild to life
threatening, and febrile illnesses can exacerbate chronic mild
hemolysis due to the elevation in complements as part of the acute
phase reaction. Diagnosis of this anemia is made by measuring the
cold agglutin IgM antibody titers– the antibody titers measured
at 4° C are greatly increased (up to 1:1 × 106) from a normal low
titer of <1:16 at 4° C. Also, the thermal amplitude of the antibody
is increased, and the antibody binds to the surface of RBCs at
temperatures as high as 28° to 32° C, when the normal thermal
amplitude of the antibody does not allow binding between 20 to
37 ° C.1
Rapidly developing anemia with defects in tissue perfusion, such as
in our patient, requires urgent treatment. However, treatment with
blood transfusions can be difficult due to the ongoing hemolysis.
Transfusion of warmed blood decreases the hemolysis because the
antibody binding is impaired at warmer temperatures. Steroids
are often given in conjunction with transfusions to blunt the
patient’s immune response. Inducing hypothermia is sometimes
part of the treatment in attempt to maximize tissue oxygen
delivery.2 Splenectomy, although mentioned in the literature, is
usually not helpful since the macrophages are primarily cleared in
the liver. There are also a few reports of successful treatment with
monoclonal antibodies; however, they are not used for rapidly
progressing hemolytic anemia.3
Patients with primary cold agglutinin disease usually have moderate
anemia with occasional attacks of acrocyanosis when exposed to
cold. These patients are generally elderly (70 to 80 years old) and
have underlying malignancies. When a younger patient such as
ours presents presents with acute onset of cold agglutinin disease,
an infection with either Mycoplasma pneumoniae or infectious
mononucleosis should be suspected. In these patients, additional
treatment of the underlying disorder is helpful when anemia is not
as rapidly progressive as in our patient.
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